Radiation Oncology's Place in Payment Reform: ASTRO Advocates for a Place at the Table.


Journal

JCO oncology practice
ISSN: 2688-1535
Titre abrégé: JCO Oncol Pract
Pays: United States
ID NLM: 101758685

Informations de publication

Date de publication:
12 2021
Historique:
pubmed: 16 9 2021
medline: 1 2 2022
entrez: 15 9 2021
Statut: ppublish

Résumé

In its current form, the Radiation Oncology Model (RO Model) prioritizes payment cuts over true value-based payment transformation. With significant modifications to the payment methodology, the reporting requirements, and recognition of the unique challenges faced by disadvantaged populations, the RO Model can protect patient access to care, preserve the physician-patient decision-making process, and ensure the delivery of high-quality, efficient radiation therapy treatment. The American Society for Radiation Oncology has spent several years advocating for a meaningful alternative payment model for radiation oncology and continues to push The Center for Medicare and Medicaid Innovation for changes to the RO Model that will recognize these key outcomes.

Identifiants

pubmed: 34524836
doi: 10.1200/OP.21.00294
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

777-781

Auteurs

Anne Hubbard (A)

American Society for Radiation Oncology, Arlington, VA.

Najeeb Mohideen (N)

Northwest Community Healthcare, Arlington Heights, IL.

William Hartsell (W)

Radiation Oncology Consultants, Chicago, IL.

Peter Orio (P)

Dana-Farber Cancer Institute, Boston, MA.

Catheryn Yashar (C)

University of California San Diego, San Diego, CA.

Vivek Kavadi (V)

The US Oncology Network, Woodlands, TX.

Brian Kavanagh (B)

University of Colorado, Aurora, CO.

Dave Adler (D)

American Society for Radiation Oncology, Arlington, VA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH